Today, TRIMU 5 continues to be a topic of great interest and relevance in today's society. Whether due to its impact on people's daily lives, its influence on popular culture or its importance in academia and science, TRIMU 5 continues to be the subject of constant analysis and debate. In this article, we will explore different aspects related to TRIMU 5, from its history and evolution to its current state and possible future developments. Through this analysis, we hope to shed light on the importance and relevance of TRIMU 5 today and its impact on different aspects of society.
![]() | |
Names | |
---|---|
IUPAC name
L-Tyrosyl-N-{acetyl}-D-alaninamide
| |
Systematic IUPAC name
(2R)-2-Amino-3-(4-hydroxyphenyl)-N-acetamido}-1-oxopropan-2-yl]propanamide | |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C19H30N4O4 | |
Molar mass | 378.466 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa).
|
TRIMU-5 is a selective agonist of the μ2-opioid receptor and antagonist of the μ1-opioid receptor.[1][2] It produces analgesia in animals that differs from that of conventional μ-opioid receptor agonists but that can still be blocked by μ-opioid receptor antagonists.[1] TRIMU-5 can also block the analgesic effects of μ-opioid receptor agonists like morphine.[1] In addition to analgesia, TRIMU-5 inhibits gastrointestinal transit, a known effect of μ2-opioid receptor activation.[1]